Literature DB >> 11978927

Determinants of adherence in adults with cystic fibrosis.

Lisa J Kettler1, S M Sawyer, H R Winefield, H W Greville.   

Abstract

Cystic fibrosis (CF) is now as much a disease of adults as of children and adolescents. An important focus of recent research has been the impact of the complex, expensive, and time consuming routine of self-care and medical treatment that is required by adults with CF to maintain health. A growing concern for medical and allied health teams is the issue of patient adherence to prescribed health management plans. A summary of the particular medical and treatment context of CF is followed by a review of adherence measurement issues and the determinants of adherence to treatment regimens in people with CF, primarily adults. Evidence for factors which influence adherence decisions of people with CF is examined. The medical and psychological aspects of this complex problem have not been adequately addressed because of difficulties with definition and measurement. Only a small proportion of the variance in adherence has been accounted for in the literature. New measurement technologies and new theoretical directions offer promise for a better understanding of this complex and important issue and may result in more effective intervention strategies to improve adherence.

Entities:  

Mesh:

Year:  2002        PMID: 11978927      PMCID: PMC1746335          DOI: 10.1136/thorax.57.5.459

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  33 in total

1.  Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers.

Authors:  C E Ievers; R T Brown; D Drotar; D Caplan; B S Pishevar; R G Lambert
Journal:  J Dev Behav Pediatr       Date:  1999-10       Impact factor: 2.225

2.  Compliance and self-medication in cystic fibrosis.

Authors:  A Meyers; T F Dolan; D Mueller
Journal:  Am J Dis Child       Date:  1975-09

3.  A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence.

Authors:  M Starr; S Sawyer; J Carlin; C Powell; R Newman; P Johnson
Journal:  J Paediatr Child Health       Date:  1999-08       Impact factor: 1.954

Review 4.  Locus of control and health: a review of the literature.

Authors:  B D Wallston; K A Wallston
Journal:  Health Educ Monogr       Date:  1978

5.  Metered-dose inhaler usage in subjects with asthma: comparison of Nebulizer Chronolog and daily diary recordings.

Authors:  H Gong; M S Simmons; V A Clark; D P Tashkin
Journal:  J Allergy Clin Immunol       Date:  1988-07       Impact factor: 10.793

6.  Correlates of psychosocial adjustment among young adults with cystic fibrosis.

Authors:  J R Moise; D Drotar; C F Doershuk; R C Stern
Journal:  J Dev Behav Pediatr       Date:  1987-06       Impact factor: 2.225

7.  A behavioral medicine perspective on adherence to long-term medical regimens.

Authors:  L H Epstein; P A Cluss
Journal:  J Consult Clin Psychol       Date:  1982-12

8.  Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors.

Authors:  S P Conway; A M Morton; B Oldroyd; J G Truscott; H White; A H Smith; I Haigh
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

9.  Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials.

Authors:  S L Spector; R Kinsman; H Mawhinney; S C Siegel; G S Rachelefsky; R M Katz; A S Rohr
Journal:  J Allergy Clin Immunol       Date:  1986-01       Impact factor: 10.793

10.  Medical compliance and coping with cystic fibrosis.

Authors:  D R Czajkowski; G P Koocher
Journal:  J Child Psychol Psychiatry       Date:  1987-03       Impact factor: 8.982

View more
  24 in total

Review 1.  How a clinical psychologist manages the problems of adults with cystic fibrosis.

Authors:  Helen Oxley; A K Webb
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

2.  Self-reported involvement of family members in the care of adults with CF.

Authors:  Kimberly McGuffie; Deborah E Sellers; Gregory S Sawicki; Walter M Robinson
Journal:  J Cyst Fibros       Date:  2007-07-16       Impact factor: 5.482

3.  Adherence and psychopathology in children and adolescents with cystic fibrosis.

Authors:  Tonya White; Judith Miller; Gail L Smith; William M McMahon
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-09-20       Impact factor: 4.785

4.  Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.

Authors:  Yu-Wei Lin; Qi Tony Zhou; Yang Hu; Nikolas J Onufrak; Siping Sun; Jiping Wang; Alan Forrest; Hak-Kim Chan; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis.

Authors:  Gregory S Sawicki; Deborah E Sellers; Walter M Robinson
Journal:  J Psychosom Res       Date:  2010-08-10       Impact factor: 3.006

6.  Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study.

Authors:  Alice Hogan; Mary-Ann Bonney; Jo-Anne Brien; Rita Karamy; Parisa Aslani
Journal:  Int J Clin Pharm       Date:  2014-11-29

7.  High treatment burden in adults with cystic fibrosis: challenges to disease self-management.

Authors:  Gregory S Sawicki; Deborah E Sellers; Walter M Robinson
Journal:  J Cyst Fibros       Date:  2008-10-26       Impact factor: 5.482

8.  Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Authors:  Antoinette Moran; Penelope Pekow; Patricia Grover; Martha Zorn; Bonnie Slovis; Joseph Pilewski; Elizabeth Tullis; Theodore G Liou; Holley Allen
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152

Review 9.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  Daniel Conole; Gillian M Keating
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.